The cardioprotection of the insulin-mediated PI3K/Akt/mTOR signaling pathway

Hong Yao1, Xiangyang Han, Xiuzhen Han

  • 1Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, 44 West Wenhua Road, Jinan, 250012, Shandong, China.

Insights

Insulin protects heart cells from apoptosis via the PI3K/Akt pathway, improving cardiac function after injury. This approach offers a promising therapeutic strategy for heart disease treatment.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Apoptosis is a key factor in myocardial infarction and other heart injuries.
  • Solely inhibiting apoptosis is insufficient for effective cardiomyocyte rescue.
  • The PI3K/Akt signaling pathway is crucial in cellular survival and function.

Purpose of the Study:

  • To review the protective mechanisms of insulin against myocardial injury.
  • To identify key molecular targets of insulin in preventing and treating heart disease.
  • To explore how insulin modulates cardiomyocyte apoptosis and cardiac function.

Main Methods:

  • Literature review of studies on insulin signaling in the heart.
  • Analysis of molecular pathways involved in insulin's cardioprotective effects.
  • Examination of studies investigating insulin's role in myocardial infarction and ischemia/reperfusion injury.

Main Results:

  • Insulin activates the PI3K/Akt pathway, inhibiting cardiomyocyte apoptosis.
  • Insulin preserves and improves regional and overall cardiac function.
  • Insulin regulates multiple signaling molecules including eNOS, FOXOs, Bad, GSK-3β, mTOR, NDRG2, and Nrf2.

Conclusions:

  • Insulin offers significant cardioprotection by inhibiting apoptosis and enhancing cardiac function.
  • Targeting the PI3K/Akt pathway with insulin presents a viable therapeutic strategy for myocardial injury.
  • Understanding insulin's molecular targets is essential for developing novel treatments for heart diseases.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K